Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Isenberg

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
BMJ Open|June 17, 2019
Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British CohortBeatriz Tejera Segura, Iñigo Rua-Figueroa, Jose Maria Pego-Reigosa, et al.
Rheumatology (Oxford, England)|October 21, 2019
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohortBeatriz Tejera Segura, Brett Sydney Bernstein, Thomas McDonnell, et al.
Rheumatology (Oxford, England)|August 5, 2019
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohortBeatriz Tejera Segura, Brett Sydney Bernstein, Thomas McDonnell, et al.
Arthritis Research & Therapy|February 8, 2014
Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort studySara Croca, Paul Bassett, Charis Pericleous, et al.
Frontiers in Immunology|October 17, 2018
Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein IThomas McDonnell, Bahar Artim-Esen, Chris Wincup, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
Lupus Science & Medicine|May 4, 2026
Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupusJyoti Bakshi, Rym Abida, Sara Croca, et al.
Arthritis Research & Therapy|April 19, 2015
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assaysBahar Artim-Esen, Charis Pericleous, Ian Mackie, et al.
Arthritis Research & Therapy|April 19, 2015
IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational studySara Croca, Paul Bassett, Sharon Chambers, et al.
The Journal of Rheumatology|March 1, 2003
Defining Clinical Improvement in Adult and Juvenile MyositisLisa G Rider, Edward H Giannini, Michael Harris-Love, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
BMJ Open|June 17, 2019
Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British CohortBeatriz Tejera Segura, Iñigo Rua-Figueroa, Jose Maria Pego-Reigosa, et al.
Rheumatology (Oxford, England)|October 21, 2019
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohortBeatriz Tejera Segura, Brett Sydney Bernstein, Thomas McDonnell, et al.
Rheumatology (Oxford, England)|August 5, 2019
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohortBeatriz Tejera Segura, Brett Sydney Bernstein, Thomas McDonnell, et al.
Arthritis Research & Therapy|February 8, 2014
Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort studySara Croca, Paul Bassett, Charis Pericleous, et al.
Frontiers in Immunology|October 17, 2018
Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein IThomas McDonnell, Bahar Artim-Esen, Chris Wincup, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
Lupus Science & Medicine|May 4, 2026
Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupusJyoti Bakshi, Rym Abida, Sara Croca, et al.
Arthritis Research & Therapy|April 19, 2015
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assaysBahar Artim-Esen, Charis Pericleous, Ian Mackie, et al.
Arthritis Research & Therapy|April 19, 2015
IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational studySara Croca, Paul Bassett, Sharon Chambers, et al.
The Journal of Rheumatology|March 1, 2003
Defining Clinical Improvement in Adult and Juvenile MyositisLisa G Rider, Edward H Giannini, Michael Harris-Love, et al.
Pageof 19